Abstract
Parkinsonism is rare in individuals younger than 40, making its coexistence with pregnancy exceptionally uncommon and clinically challenging. This case report describes the management of a 33-year-old woman with autosomal recessive Parkinson’s disease (two PARK2 gene mutations) who conceived through in vitro fertilization (IVF) due to unexplained subfertility. Her partner tested negative for the mutation. She continued levodopa throughout pregnancy and required a carefully coordinated multidisciplinary approach. She developed pregnancy-induced hypertension, which was controlled with beta-blockers. Her Parkinson’s symptoms worsened toward the end of pregnancy, requiring increased levodopa doses. Due to subfertility, impaired coordination, and mental health concerns, an elective Caesarean section was performed at 38 weeks under spinal anesthesia, resulting in the birth of a healthy baby. She received strong support from neurology, occupational therapy, and physiotherapy teams during pregnancy and the postnatal period. Although postnatal depression had been anticipated, bonding with the baby was good. This case underscores the importance of multidisciplinary, individualized care to achieve favorable maternal and fetal outcomes.
References
Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896-912.
Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002;14(2):223-236.
Bloem BR, Okun MS, Klein C. Parkinson’s disease. Lancet. 2021;397(10291):2284-2303.
Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm Vienna. 2017;124(8):901-905.
Golbe LI. Parkinson’s disease and pregnancy. Neurology. 1987;37(7):1245-1249.
Seier M, Hiller A. Parkinson’s disease and pregnancy: An updated review. Park Relat Disord. 2017;40:11-17.
Savica R, Grossardt BR, Bower JH, Boeve BF, Ahlskog JE, Rocca WA. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol. 2013;70(11):1396-1402.
Marras C, Beck JC, Bower JH, et al. Prevalence of Parkinson’s disease across North America. NPJ Park Dis. 2018;4:21.
Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591-1601.
Jain S, Goldstein DS. Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis. 2012;46(3):572-580.
Aarsland D, Creese B, Politis M, et al. Cognitive decline in Parkinson disease. Nat Rev Neurol. 2017;13(4):217-231.
Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5(3):235-245.
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427-442.
Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392(6676):605-608.
Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology. 2009;72(21 Suppl 4):S1-136.
Gray R, Ives N, Rick C, et al. Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson’s disease (PD MED): a large, open-label, pragmatic randomised trial. Lancet. 2014;384(9949):1196-1205.
Olivola S, Xodo S, Olivola E, Cecchini F, Londero AP, Driul L. Parkinson’s Disease in Pregnancy: A Case Report and Review of the Literature. Front Neurol. 2019;10:1349.
Hagell P, Odin P, Vinge E. Pregnancy in Parkinson’s disease: a review of the literature and a case report. Mov Disord. 1998;13(1):34-38.
Ahlskog JE, Geda YE, Graff-Radford NR, Petersen RC. Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc. 2011;86(9):876-884.
Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009;301(1):63-73.
Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL. The effectiveness of exercise interventions for people with Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2008;23(5):631-640.
Fan Y, Winanto, Ng SY. Replacing what’s lost: a new era of stem cell therapy for Parkinson’s disease. Transl Neurodegener. 2020;9(1):2.
Lamichhane D, Narayanan NS, Gonzalez-Alegre P. Two cases of pregnancy in Parkinson’s disease. Park Relat Disord. 2014;20(2):239-240.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Aasim Elhaj, Waqar Arshad

